AvKARE LLC is recalling 592 cartons of Tranexamic Acid USP Tablets (650 mg), a prescription medication used to treat heavy menstrual bleeding. The recall affects 30-tablet unit dose cartons (containing 3 strips of 10 tablets each) that failed quality testing for conductivity, indicating the presence of impurities or product degradation. Consumers who have this medication should consult their pharmacist or healthcare provider and follow instructions for return or disposal.
The tablets failed conductivity specifications, which suggests the medication may contain impurities or has begun to degrade, potentially compromising the quality and safety of the drug. No injuries or adverse events have been reported to date.
You have 2 options:
Recall number D-0875-2023; Manufactured for AvKARE Pulaski, TN.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.